Dinesh M. Kumar - Nov 8, 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Officer
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Stock symbol
ASTH
Transactions as of
Nov 8, 2024
Transactions value $
$0
Form type
4
Date filed
11/12/2024, 04:39 PM
Previous filing
Aug 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Award $0 +67.2K +44.94% $0.00 217K Nov 8, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest subject to the achievement of certain performance goals, provided the Reporting Person is still employed with the Issuer on the date of vesting.
F2 Includes 214,370 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 85,130 shares, which will vest in three equal annual installments beginning on January 23, 2025 (ii) 9,790 shares, which will vest in three equal semi-annual installments beginning on January 1, 2025; and (iii) grants of 16,316, 16,316, 13,053, 6,527 and 67,238 shares, each of which will vest subject to the achievement of certain performance goals.

Remarks:

Chief Medical Officer of Astrana Health Enablement of Nevada, Inc., a wholly owned subsidiary of Astrana Health, Inc.